| 1 |
Todori M, Yanagawa N, Ito K, Ito Y, Suzuki M, Sugimoto R, Osakabe M, Uesugi N, Sugai T. Rectal Carcinoma With a Sarcomatoid Component: A Case Report With Detailed Immunohistochemistry, Molecular Analysis, and Literature Review. Int J Surg Pathol 2023;:10668969231160253. [PMID: 36890707 DOI: 10.1177/10668969231160253] [Reference Citation Analysis]
|
| 2 |
Merhi M, Ahmad F, Taib N, Inchakalody V, Uddin S, Shablak A, Dermime S. The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update. Semin Cancer Biol 2023;89:1-17. [PMID: 36621515 DOI: 10.1016/j.semcancer.2023.01.001] [Reference Citation Analysis]
|
| 3 |
Calaf GM. Breast carcinogenesis induced by organophosphorous pesticides. Adv Pharmacol 2023;96:71-117. [PMID: 36858780 DOI: 10.1016/bs.apha.2022.10.003] [Reference Citation Analysis]
|
| 4 |
Guo S, Li F, Wills M, Yip J, Wehbe A, Peng C, Geng X, Ding Y, Zhang F. Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/6886752] [Reference Citation Analysis]
|
| 5 |
Wang Z, Strasser A, Kelly GL. Should mutant TP53 be targeted for cancer therapy? Cell Death Differ 2022;29:911-20. [PMID: 35332311 DOI: 10.1038/s41418-022-00962-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Bemmerlein L, Deniz IA, Karbanová J, Jacobi A, Drukewitz S, Link T, Göbel A, Sevenich L, Taubenberger AV, Wimberger P, Kuhlmann JD, Corbeil D. Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity. Cancers (Basel) 2022;14:603. [PMID: 35158871 DOI: 10.3390/cancers14030603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Liu F, Li X, Yan H, Wu J, Yang Y, He J, Chen J, Jiang Z, Wu F, Jiang Z. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Zhang Q, Zhang Y, Zhang J, Zhang D, Li M, Yan H, Zhang H, Song L, Wang J, Hou Z, Yang Y, Zou X. p66α Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53. Cells 2021;10:3593. [PMID: 34944103 DOI: 10.3390/cells10123593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B, Shen J, Cai L, Cai X, Chen M. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol 2021;14:157. [PMID: 34583722 DOI: 10.1186/s13045-021-01169-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 10 |
Arsic N, Slatter T, Gadea G, Villain E, Fournet A, Kazantseva M, Allemand F, Sibille N, Seveno M, de Rossi S, Mehta S, Urbach S, Bourdon JC, Bernado P, Kajava AV, Braithwaite A, Roux P. Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells. Nat Commun 2021;12:5463. [PMID: 34526502 DOI: 10.1038/s41467-021-25550-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Giebel N, de Jaime-Soguero A, García Del Arco A, Landry JJM, Tietje M, Villacorta L, Benes V, Fernández-Sáiz V, Acebrón SP. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling. EMBO Rep 2021;22:e51415. [PMID: 33786993 DOI: 10.15252/embr.202051415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 12 |
Xu H, Liu L, Li W, Zou D, Yu J, Wang L, Wong CC. Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications. Oncogene 2021;40:1555-69. [PMID: 33323976 DOI: 10.1038/s41388-020-01587-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Escobar-Hoyos LF, Penson A, Kannan R, Cho H, Pan CH, Singh RK, Apken LH, Hobbs GA, Luo R, Lecomte N, Babu S, Pan FC, Alonso-Curbelo D, Morris JP 4th, Askan G, Grbovic-Huezo O, Ogrodowski P, Bermeo J, Saglimbeni J, Cruz CD, Ho YJ, Lawrence SA, Melchor JP, Goda GA, Bai K, Pastore A, Hogg SJ, Raghavan S, Bailey P, Chang DK, Biankin A, Shroyer KR, Wolpin BM, Aguirre AJ, Ventura A, Taylor B, Der CJ, Dominguez D, Kümmel D, Oeckinghaus A, Lowe SW, Bradley RK, Abdel-Wahab O, Leach SD. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Cancer Cell 2020;38:198-211.e8. [PMID: 32559497 DOI: 10.1016/j.ccell.2020.05.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 14 |
Klinakis A, Rampias T. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection. EBioMedicine 2020;58:102905. [PMID: 32739866 DOI: 10.1016/j.ebiom.2020.102905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 15 |
Zhou X, Hao Q, Lu H. Mutant p53 in cancer therapy-the barrier or the path. J Mol Cell Biol. 2019;11:293-305. [PMID: 30508182 DOI: 10.1093/jmcb/mjy072] [Cited by in Crossref: 106] [Cited by in F6Publishing: 113] [Article Influence: 35.3] [Reference Citation Analysis]
|
| 16 |
Hu P, Huang Y, Gao Y, Yan H, Li X, Zhang J, Wang Y, Zhao Y. Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis. DNA Cell Biol 2020;39:522-32. [PMID: 32040344 DOI: 10.1089/dna.2019.5116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 17 |
De A, De A, Sharma R, Suo W, Sharma M. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets. J Cancer 2020;11:1927-39. [PMID: 32194804 DOI: 10.7150/jca.36919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 18 |
Tang Q, Su Z, Gu W, Rustgi AK. Mutant p53 on the Path to Metastasis. Trends Cancer 2020;6:62-73. [PMID: 31952783 DOI: 10.1016/j.trecan.2019.11.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 19 |
Datta A, Das P, Dey S, Ghuwalewala S, Ghatak D, Alam SK, Chatterjee R, Roychoudhury S. Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53. Genes (Basel) 2019;10:E852. [PMID: 31661871 DOI: 10.3390/genes10110852] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Farajihaye Qazvini F, Samadi N, Saffari M, Emami-Razavi AN, Shirkoohi R. Fibroblast growth factor-10 and epithelial-mesenchymal transition in colorectal cancer. EXCLI J 2019;18:530-9. [PMID: 31611737 DOI: 10.17179/excli2018-1784] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 21 |
Jin Y, Lu X, Wang M, Zhao X, Xue L. X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF-β signaling pathway in esophageal cancer cells. Cell Biosci 2019;9:76. [PMID: 31548877 DOI: 10.1186/s13578-019-0338-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 22 |
Thomas LW, Esposito C, Stephen JM, Costa ASH, Frezza C, Blacker TS, Szabadkai G, Ashcroft M. CHCHD4 regulates tumour proliferation and EMT-related phenotypes, through respiratory chain-mediated metabolism. Cancer Metab 2019;7:7. [PMID: 31346464 DOI: 10.1186/s40170-019-0200-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
He S, Carman CV, Lee JH, Lan B, Koehler S, Atia L, Park CY, Kim JH, Mitchel JA, Park JA, Butler JP, Lu Q, Fredberg JJ. The tumor suppressor p53 can promote collective cellular migration. PLoS One 2019;14:e0202065. [PMID: 30707705 DOI: 10.1371/journal.pone.0202065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 24 |
Thomas LW, Esposito C, Stephen JM, Costa ASH, Frezza C, Blacker TS, Szabadkai G, Ashcroft M. CHCHD4 regulates a proliferation-EMT switch in tumour cells, through respiratory complex I mediated metabolism.. [DOI: 10.1101/513531] [Reference Citation Analysis]
|
| 25 |
Cardona AF, Zatarain-Barrón ZL, Rubio C, Martínez S, Ruiz-Patiño A, Ricaurte L, Serna A, Barrios R, Garzón JC, Navarrete C, Balaguera A, Corrales L, Rojas L, Arrieta O. Probable hereditary familial overlap syndrome with multiple synchronous lung tumors. Lung Cancer 2018;124:279-82. [PMID: 30268473 DOI: 10.1016/j.lungcan.2018.08.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
He S, Carman CV, Lee JH, Lan B, Koehler S, Atia L, Park CY, Kim JH, Mitchel JA, Park J, Butler JP, Lee SW, Fredberg JJ. The tumor suppressor p53 promotes carcinoma invasion and collective cellular migration.. [DOI: 10.1101/380600] [Reference Citation Analysis]
|
| 27 |
Oikawa T, Otsuka Y, Sabe H. p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations. Cancers (Basel) 2018;10:E162. [PMID: 29799511 DOI: 10.3390/cancers10060162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 28 |
Denisenko TV, Pivnyuk AD, Zhivotovsky B. p53-Autophagy-Metastasis Link. Cancers (Basel). 2018;10. [PMID: 29783720 DOI: 10.3390/cancers10050148] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 29 |
Oikawa T, Otsuka Y, Onodera Y, Horikawa M, Handa H, Hashimoto S, Suzuki Y, Sabe H. Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity. Sci Rep 2018;8:1595. [PMID: 29371630 DOI: 10.1038/s41598-018-20043-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 30 |
Lee S, Yoon HI, Na JH, Jeon S, Lim S, Koo H, Han S, Kang S, Park S, Moon S, Park JH, Cho YW, Kim B, Kim SK, Lee T, Kim D, Lee S, Pomper MG, Kwon IC, Kim K. In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface. Biomaterials 2017;139:12-29. [DOI: 10.1016/j.biomaterials.2017.05.050] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 31 |
Ou QJ, Wu XJ, Peng JH, Zhang RX, Lu ZH, Jiang W, Zhang L, Pan ZZ, Wan DS, Fang YJ. Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells. Mol Med Rep 2017;16:5769-78. [PMID: 28849238 DOI: 10.3892/mmr.2017.7375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 32 |
Hauck PM, Wolf ER, Olivos DJ 3rd, Batuello CN, McElyea KC, McAtarsney CP, Cournoyer RM, Sandusky GE, Mayo LD. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function. Mol Cancer Res 2017;15:1598-607. [PMID: 28784612 DOI: 10.1158/1541-7786.MCR-17-0174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 33 |
Dabiri Y, Kalman S, Gürth CM, Kim JY, Mayer V, Cheng X. The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells. Sci Rep 2017;7:5423. [PMID: 28710427 DOI: 10.1038/s41598-017-05813-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 34 |
Li W, Lai B, Yang X, Zhang C, Wang H. A truncated p53 in human lung cancer cells as a critical determinant of proliferation and invasiveness. Tumour Biol 2017;39:101042831770382. [DOI: 10.1177/1010428317703824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 35 |
Zhang P, Zuo Z, Wu A, Shang W, Bi R, Jin Q, Wu J, Jiang L. miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines. Oncol Lett 2017;13:1789-96. [PMID: 28454325 DOI: 10.3892/ol.2017.5654] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 36 |
Faghihloo E, Sadeghizadeh M, Shahmahmoodi S, Mokhtari-azad T. Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression. Cancer Gene Ther. [DOI: 10.1038/cgt.2016.51] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 37 |
Gadea G, Arsic N, Fernandes K, Diot A, Joruiz SM, Abdallah S, Meuray V, Vinot S, Anguille C, Remenyi J, Khoury MP, Quinlan PR, Purdie CA, Jordan LB, Fuller-Pace FV, de Toledo M, Cren M, Thompson AM, Bourdon JC, Roux P. TP53 drives invasion through expression of its Δ133p53β variant. Elife 2016;5:e14734. [PMID: 27630122 DOI: 10.7554/eLife.14734] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 38 |
Chowdhury AR, Long A, Fuchs SY, Rustgi A, Avadhani NG. Mitochondrial stress-induced p53 attenuates HIF-1α activity by physical association and enhanced ubiquitination. Oncogene 2017;36:397-409. [PMID: 27345397 DOI: 10.1038/onc.2016.211] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 39 |
Jin M, Park IA, Kim JY, Chung YR, Im S, Lee K, Moon H, Han W, Noh D, Ryu HS. New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer. Tumor Biol 2016;37:11017-24. [DOI: 10.1007/s13277-016-4990-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 40 |
Králová V, Hanušová V, Rudolf E, Čáňová K, Skálová L. Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro. Journal of Pharmacy and Pharmacology 2016;68:208-18. [DOI: 10.1111/jphp.12503] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 41 |
Liu X, Ji Q, Fan Z, Li Q. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents. Future Oncol. 2015;11:2911-2922. [PMID: 26414153 DOI: 10.2217/fon.15.235] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 42 |
Garufi A, D'Orazi V, Crispini A, D'Orazi G. Zn(II)-curc targets p53 in thyroid cancer cells. Int J Oncol 2015;47:1241-8. [PMID: 26314369 DOI: 10.3892/ijo.2015.3125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 43 |
Arsic N, Gadea G, Lagerqvist EL, Busson M, Cahuzac N, Brock C, Hollande F, Gire V, Pannequin J, Roux P. The p53 isoform Δ133p53β promotes cancer stem cell potential. Stem Cell Reports 2015;4:531-40. [PMID: 25754205 DOI: 10.1016/j.stemcr.2015.02.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 44 |
Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 45 |
Kim SH, Kang JG, Kim CS, Ihm S, Choi MG, Yoo HJ, Lee SJ. Herbimycin A inhibits cell growth with reversal of epithelial–mesenchymal transition in anaplastic thyroid carcinoma cells. Biochemical and Biophysical Research Communications 2014;455:363-70. [DOI: 10.1016/j.bbrc.2014.11.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 46 |
Fernandez SV, Bingham C, Fittipaldi P, Austin L, Palazzo J, Palmer G, Alpaugh K, Cristofanilli M. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res 2014;16:445. [PMID: 25307991 DOI: 10.1186/s13058-014-0445-3] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 47 |
Lenfert E, Maenz C, Heinlein C, Jannasch K, Schumacher U, Pantel K, Tolstonog GV, Deppert W, Wegwitz F. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice. Int J Cancer 2015;136:E521-33. [PMID: 25195563 DOI: 10.1002/ijc.29186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 48 |
Satow R, Hirano T, Batori R, Nakamura T, Murayama Y, Fukami K. Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells. Proc Natl Acad Sci U S A 2014;111:13505-10. [PMID: 25197077 DOI: 10.1073/pnas.1405374111] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 49 |
Gorrini C. Discovery of a p53 variant that controls metastasis. Proc Natl Acad Sci U S A 2014;111:11576-7. [PMID: 25082893 DOI: 10.1073/pnas.1405580111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 50 |
Muller PA, Vousden KH. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell. 2014;25:304-317. [PMID: 24651012 DOI: 10.1016/j.ccr.2014.01.021] [Cited by in Crossref: 983] [Cited by in F6Publishing: 1034] [Article Influence: 109.2] [Reference Citation Analysis]
|
| 51 |
Arjonen A, Kaukonen R, Mattila E, Rouhi P, Högnäs G, Sihto H, Miller BW, Morton JP, Bucher E, Taimen P, Virtakoivu R, Cao Y, Sansom OJ, Joensuu H, Ivaska J. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J Clin Invest 2014;124:1069-82. [PMID: 24487586 DOI: 10.1172/JCI67280] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 52 |
Song Y, Zhang C, Cao Z, Xu J, Wang L, Lin X. [Significance of epithelial-mesenchaymal transition phenotype in invasive tumor front cells of lung squamous cell carcinoma]. Zhongguo Fei Ai Za Zhi 2014;17:315-20. [PMID: 24758906 DOI: 10.3779/j.issn.1009-3419.2014.04.05] [Reference Citation Analysis]
|
| 53 |
Li H, Li M, Xu D, Zhao C, Liu G, Wang F. Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition. Biochem Biophys Res Commun 2014;446:347-51. [PMID: 24607896 DOI: 10.1016/j.bbrc.2014.02.119] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 54 |
Son H, Moon A. Epithelial-mesenchymal Transition and Cell Invasion. Toxicol Res 2010;26:245-52. [PMID: 24278531 DOI: 10.5487/TR.2010.26.4.245] [Cited by in Crossref: 167] [Cited by in F6Publishing: 184] [Article Influence: 16.7] [Reference Citation Analysis]
|
| 55 |
Perez CJ, Rundhaug JE, Johnson DG, Oberyszyn TM, Tober KL, Kusewitt DF. Slug expression in mouse skin and skin tumors is not regulated by p53. J Invest Dermatol 2014;134:566-8. [PMID: 24008423 DOI: 10.1038/jid.2013.363] [Reference Citation Analysis]
|
| 56 |
Lafitte M, Moranvillier I, Garcia S, Peuchant E, Iovanna J, Rousseau B, Dubus P, Guyonnet-Dupérat V, Belleannée G, Ramos J, Bedel A, de Verneuil H, Moreau-Gaudry F, Dabernat S. FGFR3 has tumor suppressor properties in cells with epithelial phenotype. Mol Cancer 2013;12:83. [PMID: 23902722 DOI: 10.1186/1476-4598-12-83] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 57 |
Li Z, Li N, Wu M, Li X, Luo Z, Wang X. Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. Mol Cell Biochem 2013;381:233-42. [PMID: 23744532 DOI: 10.1007/s11010-013-1707-6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 58 |
Yeudall WA, Wrighton KH, Deb S. Mutant p53 in cell adhesion and motility. Methods Mol Biol 2013;962:135-46. [PMID: 23150443 DOI: 10.1007/978-1-62703-236-0_11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
Cong NN, Zhang QY. Role of EMT in gastrointestinal tract tumors. Shijie Huaren Xiaohua Zazhi 2013; 21(3): 205-210 [DOI: 10.11569/wcjd.v21.i3.205] [Reference Citation Analysis]
|
| 60 |
Termén S, Tan E, Heldin C, Moustakas A. p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β. J Cell Physiol 2013;228:801-13. [DOI: 10.1002/jcp.24229] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 61 |
D'Costa ZJ, Jolly C, Androphy EJ, Mercer A, Matthews CM, Hibma MH. Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PLoS One 2012;7:e48954. [PMID: 23189137 DOI: 10.1371/journal.pone.0048954] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 62 |
Xu HX, Ma WQ, Yang RJ, Wang YM, Wang LJ, Zang LQ, He XX. Small interfering RNA-mediated MIF knockdown reduces cell invasion in murine colorectal cancer cell line CT-26. Shijie Huaren Xiaohua Zazhi 2012; 20(31): 3000-3004 [DOI: 10.11569/wcjd.v20.i31.3000] [Reference Citation Analysis]
|
| 63 |
Jing Y, Han Z, Liu Y, Sun K, Zhang S, Jiang G, Li R, Gao L, Zhao X, Wu D, Cai X, Wu M, Wei L. Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One. 2012;7:e43272. [PMID: 22952657 DOI: 10.1371/journal.pone.0043272] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 64 |
Walerych D, Napoli M, Collavin L, Del Sal G. The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis 2012;33:2007-17. [PMID: 22822097 DOI: 10.1093/carcin/bgs232] [Cited by in Crossref: 188] [Cited by in F6Publishing: 199] [Article Influence: 17.1] [Reference Citation Analysis]
|
| 65 |
Khapare N, Kundu ST, Sehgal L, Sawant M, Priya R, Gosavi P, Gupta N, Alam H, Karkhanis M, Naik N, Vaidya MM, Dalal SN. Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis. PLoS One 2012;7:e38561. [PMID: 22701666 DOI: 10.1371/journal.pone.0038561] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 66 |
Fujita T, Gotohda N, Kato Y, Kinoshita T, Takahashi S, Konishi M, Daiko H, Nishimura M, Kuwata T, Ochiai A, Kinoshita T. Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer 2012;15:179-87. [PMID: 21987353 DOI: 10.1007/s10120-011-0094-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 67 |
D'Costa ZJ, Leong CM, Shields J, Matthews C, Hibma MH. Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression. Invest New Drugs 2012;30:2236-51. [PMID: 22359217 DOI: 10.1007/s10637-012-9803-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 68 |
Tang FY, Pai MH, Chiang EP. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem. 2012;23:1302-1313. [PMID: 22221675 DOI: 10.1016/j.jnutbio.2011.07.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 69 |
Yi Q, Zhao X, Huang Y, Ma T, Zhang Y, Hou H, Cooke HJ, Yang DQ, Wu M, Shi Q. p53 dependent centrosome clustering prevents multipolar mitosis in tetraploid cells. PLoS One 2011;6:e27304. [PMID: 22076149 DOI: 10.1371/journal.pone.0027304] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 70 |
Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2010;1:651-661. [PMID: 21317460 DOI: 10.18632/oncotarget.199] [Cited by in Crossref: 209] [Cited by in F6Publishing: 237] [Article Influence: 17.4] [Reference Citation Analysis]
|
| 71 |
Chang HY, Kao MC, Way TD, Ho CT, Fu E. Diosgenin suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition by down-regulation of Mdm2 and vimentin. J Agric Food Chem. 2011;59:5357-5363. [PMID: 21504235 DOI: 10.1021/jf200598w] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 72 |
Emami S. Interplay between p53-family, their regulators, and PARPs in DNA repair. Clin Res Hepatol Gastroenterol 2011;35:98-104. [PMID: 21177056 DOI: 10.1016/j.gcb.2010.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 73 |
Puppin C, Passon N, Frasca F, Vigneri R, Tomay F, Tomaciello S, Damante G. In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription. Cell Oncol 2011;34:131-40. [DOI: 10.1007/s13402-011-0009-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 74 |
Cheng JC, Auersperg N, Leung PC. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin. Oncogene 2011;30:1020-31. [PMID: 20972462 DOI: 10.1038/onc.2010.486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
|
